VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice

Regulatory Peptides

Volumn 116, Issue 1-3, 2003, Pages 1-12

  Karacay, Bahri ^a   O'Dorisio, M Sue ^a   Summers, Monica ^b   Robinson, Michael ^b   Bonthius, Daniel J ^c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Adrenal medulla; Cerebellum; Medulloblastoma; Neuroblastoma; Transgenic mice; VPAC1

Indexed keywords

LUCIFERASE; VASOPRESSIN V1 RECEPTOR;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CEREBELLUM; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; FEMALE; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; MEDULLOBLASTOMA; MOLECULAR CLONING; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0242266559     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00170-8     Document Type: Article

References (46)

1. Brenneman D.E., Schultzberg M., Bartfai T., Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58:1992;454-460.
2. Pincus D.W., DiCicco-Bloom E.M., Black I.B. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature. 343:1990;564-567.
3. Gressens P., Hill J.M., Gozes I., Fridkin M., Brenneman D.E. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362:1993;155-158.
4. Brenneman D.E., Nicol T., Warren D., Bowers L.M. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25:1990;386-394.
5. Rayan G.M., Said S.I., Cahill S.L., Duke J. Vasoactive intestinal peptide and nerve regeneration. J. Hand Surg., Br. 16:1991;515-518.
6. O'Dorisio M.S., Fleshman D.J., Qualman S.J., O'Dorisio T.M. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regul. Pept. 37:1992;213-226.
7. Pence J.C., Shorter N.A. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res. 50:1990;5177-5183.
8. Balster D.A., O'Dorisio M.S., Albers A.R., Park S.K., Qualman S.J. Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1. Regul. Pept. 109:2002;155-165.
9. Wessels-Reiker M., Haycock J.W., Howlett A.C., Strong R. Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells. J. Biol. Chem. 266:1991;9347-9350.
10. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
11. Hosoya M., Onda H., Ogi K., Masuda Y., Miyamoto Y., Ohtaki T.et al. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). Biochem. Biophys. Res. Commun. 194:1993;133-143.
12. Lutz E.M., Sheward W.J., West K.M., Morrow J.A., Fink G., Harmar A.J. The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334:1993;3-8.
13. Sreedharan S.P., Robichon A., Peterson K.E., Goetzl E.J. Cloning and expression of the human vasoactive intestinal peptide receptor [published erratum appears in Proc. Natl. Acad. Sci. USA 1993 Oct 1 90 (19) 9233]. Proc. Natl. Acad. Sci. U. S. A. 88:1991;4986-4990.
14. Sreedharan S.P., Huang J.X., Cheung M.C., Goetzl E.J. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2939-2943.
15. Adamou J.E., Aiyar N., Van Horn S., Elshourbagy N.A. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem. Biophys. Res. Commun. 209:1995;385-392.
16. Hokfelt T., Vincent S., Dalsgaard C.J., Skirboll L., Johansson O., Schultzberg M.et al. Distribution of substance P in brain and periphery and its possible role as a co-transmitter. Ciba Found. Symp. (91):1982;84-106.
17. Fruhwald M.C., O'Dorisio M.S., Fleitz J., Pietsch T., Reubi J.C. Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood. Int. J. Cancer. 81:1999;165-173.
18. Yachnis A.T., Rorke L.B., Trojanowski J.Q. Cerebellar dysplasias in humans: development and possible relationship to glial and primitive neuroectodermal tumors of the cerebellar vermis. J. Neuropathol. Exp. Neurol. 53:1994;61-71.
19. Stemple D.L., Anderson D.J. Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell. 71:1992;973-985.
20. Doupe A.J., Landis S.C., Patterson P.H. Environmental influences in the development of neural crest derivatives: glucocorticoids, growth factors, and chromaffin cell plasticity. J. Neurosci. 5:1985;2119-2142.
21. McWilliams N.B. IV-S neuroblastoma: treatment controversy revisited. Med. Pediatr. Oncol. 14:1986;41-44.
22. Kleinert R. Immunohistochemical characterization of primitive neuroectodermal tumors and their possible relationship to the stepwise ontogenetic development of the central nervous system: 1. Ontogenetic studies. Acta Neuropathol. (Berl.). 82:1991;502-507.
23. Virgolini I., Raderer M., Kurtaran A., Angelberger P., Banyai S., Yang Q.et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N. Engl. J. Med. 331:1994;1116-1121.
24. Reubi J.C. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging. J. Nucl. Med. 36:1995;1846-1853.
25. Maruno K., Absood A., Said S.I. Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14373-14378.
26. Moody T.W., Czerwinski G., Tarasova N.I., Michejda C.J. VIP-ellipticine derivatives inhibit the growth of breast cancer cells. Life Sci. 71:2002;1005-1014.
27. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning a laboratory manual. 2nd ed. 1989;Cold Spring Harbor Laboratory Press, New York.
28. Lara-Marquez M.L., O'Dorisio M.S., O'Dorisio T.M., Shah M.H., Karacay B. Selective gene expression and activation-dependent regulation of VIP Type 1 (VPC1) and Type 2 (VPAC2) in human T-cells. J. Immunol. 166:2001;2522-2530.
29. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
30. Hogan B.F., Beddington R., Constantini F., Lacy E. Manipulating the mouse embryo. A laboratory manual. 2nd ed. 1994;Cold Spring Harbor Press, New York.
31. Kadonaga J.T., Carner K.R., Masiarz F.R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51(6):1987;1079-1090.
32. Kuwahara J., Yonezawa A., Futamura M., Sugiura Y. Binding of transcription factor Sp1 to GC box DNA revealed by footprinting analysis: different contact of three zinc fingers and sequence recognition mode. Biochemistry. 32:1993;5994-6001.
33. Couvineau A., Maoret J.J., Rouyer-Fessard C., Carrero I., Laburthe M. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20. Biochem. J. 347(Pt 3):2000;623-632.
34. Couvineau A., Maoret J.J., Rouyer-Fessard C., Carrero I., Laburthe M. Cloning and functional characterization of the human VIP1/PACAP receptor promoter. Ann. N.Y. Acad. Sci. 865:1998;59-63.
35. Pei L. Molecular cloning of a novel transcriptional repressor protein of the rat type 1 vasoactive intestinal peptide receptor gene. J. Biol. Chem. 273:1998;19902-19908.
36. Courey A.J., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 55(5):1988;887-898.
37. Berg J.M. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11109-11110.
38. Tanese N., Saluja D., Vassallo M.F., Chen J.L., Admon A. Molecular cloning and analysis of two subunits of the human TFIID complex: hTAFII130 and hTAFII100. Proc. Natl. Acad. Sci. U. S. A. 93:1996;13611-13616.
39. Chen J.L., Attardi L.D., Verrijzer C.P., Yokomori K., Tjian R. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell. 79(1):1994;93-105.
40. Gill G., Pascal E., Tseng Z.H., Tjian R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 91:1994;192-196.
41. Pei L., Melmed S. Characterization of the rat vasoactive intestinal polypeptide receptor gene 5′ region. Biochem. J. 308(Pt 3):1995;719-723.
42. Heistad D.D., Marcus M.L., Said S.I., Gross P.M. Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow. Am. J. Physiol. 239:1980;H73-H80.
43. Magistretti P.J., Morrison J.H., Shoemaker W.J., Sapin V., Bloom F.E. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism. Proc. Natl. Acad. Sci. U. S. A. 78(10):1981;6535-6539.
44. Brenneman D.E., Eiden L.E. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 83(4):1986;1159-1162.
45. Gozes I., Brenneman D.E. A new concept in the pharmacology of neuroprotection. J. Mol. Neurosci. 14:2000;61-68.
46. Mazzocchi G., Malendowicz L.K., Rebuffat P., Gottardo L., Nussdorfer G.G. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland. J. Clin. Endocrinol. Metab. 87:2002;2575-2580.